Navigation Links
2009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments in Cancer Care

CLEVELAND, June 24 /PRNewswire/ -- Cancer therapies and diagnostics, including new technologies, enhanced biotech and drug developments, and the consumer market for genetic testing, will be at the center of Cleveland Clinic's 7th Annual Medical Innovation Summit, Oct. 5-7.

The Summit will bring together more than 900 leaders from throughout the healthcare industry to learn about the latest innovations in cancer care, exchange perspectives and gain actionable insights.

This year's Summit will highlight new technologies in the oncology field, giving attendees access to the latest innovations in cancer therapy, diagnostics and management. Drawing international CEOs, leading venture capitalists, entrepreneurs, renowned physicians and top technologists, the summit will examine in detail the hottest new cancer technologies, prospects for new cancer innovation, and forces shaping the markets for new cancer technology.

"This Medical Innovation Summit will bring together some of the most important thought leaders in the world of healthcare, cancer technology and venture investment. In light of the current economy, it is more important than ever to discuss the future of innovation and our increased need to support new technology," said Christopher Coburn, Executive Director of Cleveland Clinic Innovations. "Everyone has been touched in some way by cancer, and we are excited to highlight the many clinical innovations taking place in this field."

The 2009 Medical Innovation Summit will feature more than 40 international leaders, including CEOs Sam Palmisano, IBM; Daniel Vasella, M.D., Novartis; David Brennan, AstraZeneca; Richard Clark, Merck; Fred Hassan, Schering-Plough; Greg Lucier, Life Technology, FDA Commissioner Margaret Hamburg, M.D.; network correspondent Maria Bartiromo, CNBC; and the CEOs and venture investors of numerous emerging technology companies. For a complete list of speakers, visit

Summit highlights will include live surgeries, Meet the Doctor Roundtables, and sessions featuring: "Key Issues in new Cancer Technologies," "The Market for Consumer Genotyping in Oncogenomics," "the Grand Challenges in Contemporary Cancer Treatment," "The Revolution in Radiotherapy Technology," "Corporate Venturing in a time of Financial Crisis," "Maximizing Innovation in Pharma," and "Enabling New Technologies and New Therapies," and much more.

In addition, for the fourth consecutive year, Cleveland Clinic experts will present their selection of the "Top 10" medical innovations that will break through in 2010. This year's session will be led by Michael Roizen, M.D., Cleveland Clinic's Chief Wellness Officer, and New York Times bestselling author. AlixPartners will again be conducting the selection process.

The 2009 Medical Innovation Summit begins Monday, Oct. 5 at 2 p.m. Premier sponsors of the 2009 Medical Innovation Summit include The Wall Street Journal, PhRma and Premium Sponsor, General Electric.

About Cleveland Clinic Innovations

CC Innovations, the commercialization and innovation arm of Cleveland Clinic, organizes the Medical Innovation Summit, promotes innovation and is responsible for commercialization of all Cleveland Clinic technologies. CC Innovations advances product-oriented innovation and transforms promising therapies, devices and diagnostics into beneficial medical products, via spin-off companies, licensees and equity partnerships.

About Cleveland Clinic

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit multispecialty academic medical center that integrates clinical and hospital care with research and education. Cleveland Clinic was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. Approximately 1,800 full-time salaried physicians and researchers at Cleveland Clinic and Cleveland Clinic Florida represent more than 100 medical specialties and subspecialties. In 2007, there were 3.5 million outpatient visits to Cleveland Clinic and 50,455 hospital admissions. Patients came for treatment from every state and from more than 80 countries. Cleveland Clinic's Web site address is

For more information on the Medical Innovation Summit, including the agenda, please visit

SOURCE Cleveland Clinic
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
2. B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices
3. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
4. Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show
5. Campbell Alliance Launches New Practice Area Focused on Medical Affairs
6. Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences
7. Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving Recovery Through Discovery
8. Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award
9. NCIIA Honors Top Collegiate Biomedical Engineering Teams
10. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
11. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... ALBANY, New York , November 24, 2015 /PRNewswire/ ... According to a recent market research report released by ... is projected to expand at a CAGR of 17.5% ... titled "Non-invasive Prenatal Testing Market - Global Industry Analysis, ... 2022", estimates the global non-invasive prenatal testing market to ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
(Date:10/27/2015)... , Oct. 27, 2015 In the present ... of concern for various industry verticals such as banking, ... to the growing demand for secure & simplified access ... ,sectors, such as hacking of bank accounts, misuse of ... equipment such as PC,s, laptops, and smartphones are expected ...
Breaking Biology News(10 mins):